Top insider buys: May 22 – May 28, 2023

The largest open-market purchases company insiders reported on SEC Form 4 between May 22 – May 28, 2023.

Week 21, 2023

#	Company	Who bought	Shares	Value	Source
1	PRLD Prelude Therapeutics Inc	2 officers/directors Cluster buy ORBIMED ADVISORS LLC, David P. Bonita	1,739,130	$10.0M	SEC filings
2	BVS Bioventus Inc.	3 officers/directors Cluster buy William A. Hawkins, Anthony P. Bihl III, John A. Bartholdson	1,528,673	$3.1M	SEC filings
3	GEG Great Elm Group, Inc.	2 officers/directors Cluster buy Northern Right Capital Management, L.P., Matthew A. Drapkin, Jason W. Reese	593,206	$1.2M +$592K by large holders	SEC filings
4	DNA Ginkgo Bioworks Holdings, Inc.	2 officers/directors Cluster buy Shyam Sankar, Harry Sloan	750,000	$960K	SEC filings
5	EHAB Enhabit, Inc.	2 officers/directors Cluster buy L. Edward Shaw Jr., Ronald Leroy Langham Jr.	20,000	$240K	SEC filings
6	EVGO EVgo Inc.	Director David Nanus	5,882,352	$25.0M	SEC filings
7	ACAD ACADIA PHARMACEUTICALS INC	Director BAKER BROS. ADVISORS LP	896,522	$22.7M	SEC filings
8	ACDC ProFrac Holding Corp.	10% Owner THRC Holdings, LP	1,720,105	$20.5M	SEC filings
9	ET Energy Transfer LP	Executive Chairman Kelcy L. Warren	1,500,000	$19.2M	SEC filings
10	SWX Southwest Gas Holdings, Inc.	10% Owner Carl C. Icahn	314,429	$18.1M	SEC filings

Source: SEC Form 4 filings, aggregated per company over the week. Open-market purchases of $100K or more only; grants, awards, option exercises and likely IPO or offering allocations are excluded. Cluster buys (two or more officers or directors buying) rank first, then by dollar value.

Not investment advice. This page reports public SEC data and is not a recommendation to buy or sell any security.